Johnson & Johnson
Salma Jutt is a seasoned executive in the MedTech industry, currently serving as the Global Vice President of Strategy and Strategic Capabilities for Ethicon at Johnson & Johnson since February 2022. With extensive experience in commercial leadership, Jutt previously held roles including Vice President of US Sales for Ethicon and Divisional Vice President at Abbott, overseeing significant portfolios in chronic pain therapies and neuromodulation. Prior to that, Jutt occupied executive positions in biotech startups, leading global marketing initiatives for products such as Contrave® and Mysimba®. Jutt's career began at Allergan, where leadership in marketing and sales for renowned aesthetic products was established. Jutt holds an MBA from Pepperdine Graziadio Business School and a Bachelor of Commerce in Marketing from the University of Alberta, complemented by executive education at Northwestern University and leadership training at the Center for Creative Leadership.
This person is not in any teams
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.